This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignee: Dong-A Pharmaceutical Co., Ltd. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Bong-Jin Cha: Innovator in Pharmaceutical Solutions
Introduction
Bong-Jin Cha is a notable inventor based in Kyungki-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in enhancing the solubility of drugs. His innovative approach has led to advancements that benefit oral administration of medications.
Latest Patents
Bong-Jin Cha holds a patent for "Intraconazole exhibiting an improved solubility, a method of preparing the same and a pharmaceutical composition for oral administration comprising the same." This patent focuses on reducing the particle diameter of itraconazole, an insoluble drug, and transforming its crystallinity from crystalline to amorphous. This transformation significantly increases the water solubility and dissolution rate of the drug, making it more effective for oral administration.
Career Highlights
Cha is currently associated with Dong-A Pharmaceutical Co., Ltd., where he continues to work on innovative pharmaceutical solutions. His expertise in drug formulation and development has positioned him as a key player in the industry.
Collaborations
He has collaborated with notable colleagues, including Jun-Gyo Oh and Su-Eon Kim, to further enhance the research and development efforts at Dong-A Pharmaceutical.
Conclusion
Bong-Jin Cha's contributions to pharmaceutical innovations, particularly in improving drug solubility, highlight his role as a significant inventor in the industry. His work continues to pave the way for more effective oral medications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile